#DementiaCosts The Future Economic, Health and Social Care Costs of Dementia 1 March 2011

#DementiaCosts Ian Sissons Munich Health

#DementiaCosts Baroness Sally Greengross Chief Executive ILC-UK

#DementiaCosts Ramon Luengo-Fernandez Health Economics Research Centre Department of Public Health University of Oxford

The economic cost and research funding of dementia compared with other diseases Staple Inn Hall - London, 1 st March 2011 Ramón Luengo-Fernández José Leal Alastair Gray

Cost of illness studies  Provide estimates of the economic burden of health problems  Can be used to inform research priorities: More research on diseases with the greatest burden  But methods for doing these studies vary  Here, we have used a common approach across several diseases Up to date estimates Informs policy makers

Objectives 1.Estimate the economic burden of dementia, cancer, coronary heart disease and stroke in the UK in 2008: health care costs (hospital, drugs, visits to doctor, etc...) social care costs (nursing homes, hospices, etc...) unpaid care from friends and family, and losses due to premature death or absence from work. 2.Quantify governmental and charity research funding on each of these four diseases for the financial year 2007/08.

Methods – Cost of Illness study  Sources searched: Office of National Statistics, the Department of Health, the Health and Social Care Information Centre, the Department for Work and Pensions (DWP), Hospital Episode Statistics (HES), the Labour Force Survey (LFS), the Annual Survey of Hours and Earnings (ASHE), the HM Revenue and Customs Statistical Office, and the DoH Quality and Outcomes Framework  Also made use of UK published studies following cohorts of dementia patients

Methods – Research funding 1.UK government agencies providing health research funding: Research councils (e.g. Medical Research Council); Research agencies from the Departments of Health in E&W, Scotland and NI (e.g. National Institute for Health Research). 2.UK registered charities funding health research: Members of the Association for Medical Research Charities Top 200 charities, in terms of income, listed in the Charity Commission for E&W (about 75% of total income)

Results – Economic cost of dementia In terms of health, social and informal care, and productivity losses, the cost of dementia was £23 billion in 2008 Unpaid carers £12.4bn 55% Social care costs £9bn 40% Health care costs £1.2bn 5% Productivity losses £49m <1%

Results – Comparisons across diseases Annual costs of dementia (£23bn) are more than cancer (£12bn), heart disease (£8bn) and stroke (£5bn)

Results – Health and social care costs When only including costs to health and social care services, dementia also had the highest cost

Results – Research funding CancerCHDDementiaStroke Charity research funding £324m£85m£14m£6m Government research funding £267m£84m£36m£18m TOTAL funding £590m£169m£50m£23m Number of cases 2.0m2.3m0.8m1.0m Research funding per case £295£75£61£22 Health and social care cost £4.6bn£2.3bn£10.3bn£2.7bn Research spending for every £10 spent on health and social care £1.2973p5p9p

Health and social care costs and research funding by disease

Cost comparisons across Europe

Dementia research spending in the EU

Conclusions 1.The estimated economic burden of dementia (£23bn) is far greater than cancer, CHD and stroke 2.Research spending on dementia and stroke is severely underfunded in comparison with cancer and CHD 3.Good evidence showing that returns on investing in research are high More research on dementia could improve the lives of patients and their carers

#DementiaCosts Professor Alistair Burns National Clinical Director for Dementia, Department of Health Professor of Old Age Psychiatry at the University of Manchester

#DementiaCosts Jeremy Hughes Chief Executive Alzheimer's Society

#DementiaCosts Emily Holzhausen Director of Policy and Public Affairs Carers UK

#DementiaCosts The Future Economic, Health and Social Care Costs of Dementia 1 March 2011